Trophozoite exported protein 1 (TEX1)

Trophozoite exported protein 1 (TEX1) is a protein expressed by the malaria parasite Plasmodium falciparum during its intraerythrocytic developmental cycle [1]. It is localized to the Maurer's clefts, which are parasite-generated membranous structures within the host erythrocyte cytoplasm that serve as sorting stations for proteins destined for the red blood cell surface [2]. TEX1 plays a critical role in the structural organization of these clefts and is essential for the efficient trafficking of virulence factors, most notably Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) [1, 3]. By facilitating the display of PfEMP1 on the host cell surface, TEX1 indirectly contributes to the cytoadherence of infected erythrocytes to the vascular endothelium, a key process in the pathogenesis of severe malaria [2, 4]. Although no clinical drugs currently target TEX1, it is considered a potential therapeutic target because disrupting its function could impair parasite virulence and prevent the complications associated with sequestration [3, 5]. Research into TEX1 provides insights into the complex protein export machinery of Plasmodium, which is vital for parasite survival and immune evasion [1, 4]. The protein is characterized by its presence in the trophozoite stage and its export beyond the parasitophorous vacuole membrane [1]. Targeting the export machinery, including TEX1, represents a strategy to attenuate the parasite's ability to modify the host cell [5]. Sources: [1] UniProt (Q8I6R7); [2] Mundwiler-Pachlatko & Beck (2013) PLoS Pathog; [3] Heiber et al. (2013) Mol Microbiol; [4] Wickham et al. (2001) EMBO J; [5] Maier et al. (2008) Cell.

Other names

PFI1755cTEX1 proteinMaurer's cleft protein TEX1

Inhibition of TEX1 disrupts the structural integrity of Maurer's clefts, preventing the trafficking of virulence factors like PfEMP1 to the host erythrocyte surface and thereby reducing parasite cytoadherence.